Bioliberty reported raising £6.2 Million in an initial SEC Form D filing, from an offering of £2.95 Million
Round Type
Series A
EdinburghBiotechnologySoftwareHealth CareInvestors
Description
Bioliberty, a University of Edinburgh spin-out, has raised £6.2m in a Series A funding round led by the Scottish National Investment Bank. The company develops AI-enabled robotic rehabilitation technology and aims to use the funding to expand manufacturing in Scotland and grow operations in the US. Archangels participated alongside Eos Advisory, Old College Capital, Hanna Capital SEZC, and Conduit Connect. The investment is part of a broader £17.9m funding round for Scottish start-ups.
Quick answer
Bioliberty raised £6.2 Million in a Series A round, dated July 16, 2026. Investors: Old College Capital, Archangels, Eos Advisory, Hanna Capital SEZC, Conduit Connect and Scottish National Investment Bank. Bioliberty is based in Edinburgh, Scotland, United Kingdom.
- How much did Bioliberty raise?
- Bioliberty raised £6.2 Million in a Series A round on July 16, 2026.
- Who invested in Bioliberty?
- Old College Capital, Archangels, Eos Advisory, Hanna Capital SEZC, Conduit Connect and Scottish National Investment Bank are named as investors in this round.
- What does Bioliberty do?
- A UK biotech startup company passionate about independent living.
- Where is Bioliberty based and how big is it?
- Bioliberty is based in Edinburgh, Scotland, United Kingdom. Fundz records about 30 employees.
- Who are the decision-makers at Bioliberty?
- Fundz holds 2 contacts at Bioliberty, including the Co-Founder & CTO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Software around the same time
Companies in the same sectors as Bioliberty that raised within 45 days of this round, from Fundz verified event records.
- Odysight.ai raised $11M (Post-IPO Equity) on August 21, 2026.
- Magnendo raised $18M (Series A) on July 24, 2026.
- Telepatía AI raised $33M (Series A) on July 9, 2026.
- Octozi raised $3M (Seed) on July 7, 2026.
- Nerveli raised $170K (Pre-Seed) on June 29, 2026.
- RedHill Biopharma Ltd raised $6M (Post-IPO Equity) on June 18, 2026.
Who to call at Bioliberty, and when
A new round usually means Bioliberty is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Bioliberty raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bioliberty, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bioliberty. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bioliberty raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBioliberty raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.